DiaMedica (DMAC) Initiates Pivotal Ischemic Stroke Study

Published on September 14, 2021

DiaMedica (DMAC) is developing its recombinant KLK1 protein candidate, DM199 for treating patients who suffered an acute ischemic stroke in the last 2...